Prothena Corp Public (PRTA) Current Leases (2017 - 2026)
Prothena Corp Public (PRTA) recorded quarterly Current Leases of $2.9 million in Q1 2026, little changed quarter-over-quarter from $2.9 million in Q4 2025, and up 10.08% on a YoY basis from $2.6 million in Q1 2025.
Prothena Corp Public (PRTA) Current Leases (2017 - 2026) Analysis & Trends
Prothena Corp Public's Current Leases history runs 10 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Current Leases rose 10.08% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $2.9 million (up 10.08% YoY), while the FY2025 annual figure was $2.9 million, up 10.57% from the prior year.
- Current Leases was $2.9 million for Q1 2026 at Prothena Corp Public, roughly flat from $2.9 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $6.5 million in Q4 2022 to a low of $1.1 million in Q4 2023.
- Historically, Current Leases has averaged $3.6 million across 5 years, with a median of $2.9 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Current Leases slumped 82.79% in 2023, then soared 134.29% in 2024.
- A 5-year view of Current Leases shows it stood at $6.5 million in 2022, then plunged by 82.79% to $1.1 million in 2023, then jumped by 134.29% to $2.6 million in 2024, then increased by 10.57% to $2.9 million in 2025, then grew by 0.24% to $2.9 million in 2026.
- The last three Current Leases figures came in at $2.9 million (Q1 2026), $2.9 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | 2.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.88 Mn |
| Jun 30, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 2.61 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.58 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 6.47 Mn |
| Sep 30, 2022 | 6.39 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 6.05 Mn |
| Dec 31, 2021 | 5.94 Mn |
| Sep 30, 2021 | 5.83 Mn |
| Jun 30, 2021 | 5.72 Mn |